Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of making the drug known as Trikafta or Kaftrio available to people with Cystic Fibrosis through the NHS.

The European Commission formally issued the marketing authorisation for Kaftrio on 21 August. It is therefore now available to be prescribed by National Health Service clinicians to eligible patients through an interim access deal negotiated between NHS England and NHS Improvement and Vertex, the drug manufacturer.